27 Mar 2026Open access
COVID19 Sero-epidemiology and vaccine uptake in two Southern Nigerian clinicsPublisher sitePLOS Global Public Health, SARS-CoV-2 and COVID-19 Research
UniversitiesJohnson Okolie
Active, last published 2026
In sars-cov-2 and covid-19 research
Johnson
Okolie
Scholar“Research focused on SARS-CoV-2 and COVID-19 Research and adjacent fields.”
Redeemer's University
Claim Your Profile7
H-index
468
Citations
Johnson has not officially claimed their profile. If you are Johnson, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohnson Okolie is a researcher working on SARS-CoV-2 and COVID-19 Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Johnson's work has been cited 468 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
SARS-CoV-2 and COVID-19 Research×6COVID-19 epidemiological studies×5Viral Infections and Outbreaks Research×3Vaccine Coverage and Hesitancy×2Immune responses and vaccinations×2
04 · Where I am
Affiliations
Affiliation on published researchRedeemer's UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works23 Jan 2024Open access5cites
Immunological insights into COVID-19 in Southern NigeriaPublisher siteFrontiers in Immunology, SARS-CoV-2 and COVID-19 Research
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Johnson?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you